Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Optimized Flow for Obese Patients Undergoing Heart Surgery

Official title: Optimized Cardiopulmonary Bypass Flow Strategy Based on Ideal Body Weight in Obese Patients Undergoing Cardiac Surgery

Run by Centre Hospitalier Universitaire, Amiens · NCT07917494 · Data updated 2026-11-12

In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment184 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedSeptember 21, 2026
Main results expectedSeptember 2029
Study endsSeptember 2029
Registry record updatedNovember 4, 2026
Trial IDNCT07917494 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with BMI over 30 kg/m² scheduled for CPB cardiac surgery (e.g., CABG, valve surgery) at CHU Amiens.

Probably not a fit

Patients with BMI under 30 kg/m² or those not undergoing CPB may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial evaluates whether calculating CPB pump flow based on ideal body weight, rather than actual weight, affects outcomes in obese adults undergoing cardiac surgery. The approach aims to reduce hemodilution and transfusion needs by aligning flow with lean mass, potentially simplifying cannulation and reducing circulation-related stress. Eligible procedures include CABG, valve procedures, and combined surgeries requiring CPB. The study is conducted at CHU Amiens and involves standard CPB and anticoagulation management. Randomization and detailed protocol elements are not provided in the available summary.

Why it matters

Potential benefit: If successful, the approach could lower transfusion rates and blood-related complications in obese patients undergoing cardiac surgery.

How similar studies have gone: Observational data support using ideal body weight for CPB flow in obesity, but no randomized trials have confirmed benefits.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged over 18 years
* Patients with obesity (BMI \> 30 kg/m²)
* Scheduled cardiac surgery under cardiopulmonary bypass (CPB):
* Coronary artery bypass grafting (CABG)
* Aortic valve replacement
* Mitral valve repair or replacement
* Surgery on the aortic root (aortic tube, Bentall procedure, Tirone David, or others)
* Combined surgery
* Affiliation to a social security scheme
* Written informed consent

Exclusion Criteria:

* Minors
* BMI \< 30 kg/m²
* Off-pump cardiac surgery
* Surgery on the aortic arch
* Planned perioperative hypothermia \< 32ºC
* Emergency surgery
* Heart transplantation or mechanical circulatory support surgery
* Infectious endocarditis
* Participation in another clinical trial within the past 30 days
* Pregnant, parturient, or breastfeeding women
* Patients under guardianship, curatorship, or deprived of civil rights
* Advanced chronic kidney disease (renal clearance \< 30 ml/min)
* Coexisting disease with a high probability of death within 6 months
* Preoperative anemia (hemoglobin \< 10 g/dL)
* Body surface area (actual body weight) \> 2.5 m²

Where it's running

  • CHU Amiens Picardie
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.